Alemtuzumab May Reduce Renal-Transplant Rejection - MD News (press release) PDF Print
MD News (press release)
In renal-transplant patients at low risk of rejection, biopsy-confirmed acute rejection is less frequent with alemtuzumab than conventional induction therapy, according to a study published in the May 19 issue of the New England Journal of Medicine.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.